Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 16.678% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) CCNC(=O)C/C(C)=N/NC(=O)C(=O)Nc1ccc(CC)cc1
b) CCOC(=O)CSc1ncnc2c1nnn2-c1ccc(F)cc1
c) c1cc(N2CCCC2)ccc1C(c1nnnn1C1CCCCC1)N1CCOCC1
d) NC(=O)CSc1ncnc2c1nnn2Cc1ccc(F)cc1
Answer: c. c1cc(N2CCCC2)ccc1C(c1nnnn1C1CCCCC1)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1cc(N2CCCC2)ccc1C(c1nnnn1C1CCCCC1)N1CCOCC1
c1cc(N2CCCC2)ccc1C(c1nnnn1C1CCCCC1)N1CCOCC1
4-[(1-cyclohexyltetrazol-5-yl)-(4-pyrrolidin-1-ylphenyl)methyl]morpholine